Modulation of Rapid Plasminogen Activator Inhibitor in Plasma by Stanozolol
1984 ◽
Vol 51
(03)
◽
pp. 396-397
◽
Keyword(s):
SummaryFibrinolytic activity in plasma euglobulin fractions can be increased by oral administration of stanozolol. This increase is not caused by increased synthesis or release of tissue-type plasminogen activator. A decreased level of fast acting t-PA inhibition is very probably the cause of the higher activity. These results suggest that this inhibition has a regulatory role on fibrinolysis in vivo.
1987 ◽
2005 ◽
Vol 30
(4)
◽
pp. 552-558
◽
1996 ◽
Vol 75
(05)
◽
pp. 801-807
◽
1986 ◽
Vol 55
(01)
◽
pp. 065-069
◽
1990 ◽
Vol 63
(03)
◽
pp. 345-348
◽
2019 ◽
1988 ◽
Vol 263
(12)
◽
pp. 5797-5803
◽
1991 ◽
Vol 2
(3)
◽
pp. 459-464
◽